课题基金 / 基金详情

Does placental transfusion prevent death and disability in very preterm infants? Childhood follow up in the NHMRC Australian Placental Transfusion Study.

Does placental transfusion prevent death and disability in very preterm infants? Childhood follow up in the NHMRC Australian Placental Transfusion Study.
胎盘输血能否预防极早产儿的死亡和残疾?
批准号:
nhmrc : 1086865
负责人:
A/Pr Kei Lui
金额:
$59.31万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2015
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2015-01-01 至 2018-12-31

项目摘要

项目成果

A/Pr Kei Lui的其他基金

相似基金

相关文献

中文摘要
翻译
全球每年有100万名婴儿在怀孕30周之前出生。许多人死亡或面临终身残疾。通过延迟夹住脐带(DCC)来加强这些婴儿的胎盘输注是一种简单的程序,可以减少儿童时期的死亡率和主要残疾。澳大利亚胎盘输血研究(APTS),有史以来最大的延迟夹闭试验,将跟踪1200名早产儿童,以评估DCC在2岁时是否对儿童有好处。
英文摘要
A million babies are born before 30 weeks gestation worldwide each year. Many die or face a lifetime of disability. Enhancing placental transfusion in these infants by deferred clamping of the umbilical cord (DCC) is a simple procedure that may reduce mortality and major disability in childhood. The Australian Placental Transfusion Study (APTS), the largest ever RCT of deferred clamping, will follow up 1200 children born preterm to evaluate if DCC has childhood benefits at 2 years age.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TORPIDO2- Targeted Oxygen for Resuscitation of Preterm Infants effects on Developmental Outcomes 2
  • 批准号:
    nhmrc : 1089056
  • 项目类别:
    Project Grants
  • 资助金额:
    $152.93万
  • 财政年份:
    2015
  • 负责人:
    A/Pr Kei Lui
  • 依托单位:
海外基金